Armata Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $966 |
Gross Profit | -315 | 649 | ||
EBITDA | 6,260 | -2,245 | 12,019 | -22,884 |
EBIT | 5,880 | -2,558 | 11,704 | -23,201 |
Net Income | 2,600 | -5,481 | 8,986 | -25,021 |
Net Change In Cash | 0 | 0 | 0 | 966 |
Free Cash Flow | -7,850 | -9,203 | -11,543 | -10,834 |
Cash | 9,291 | 17,141 | 26,405 | 37,860 |
Basic Shares | 59,082 | 36,180 | 58,246 | 36,124 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $4,529 | $5,508 | $4,474 |
Gross Profit | -29,241 | 4,616 | -15,541 | |
EBITDA | -42,436 | -39,918 | -36,054 | -22,653 |
EBIT | -29,658 | -40,890 | -36,946 | -23,822 |
Net Income | -18,916 | -69,045 | -36,888 | -23,219 |
Net Change In Cash | 0 | 4,529 | 5,508 | 4,474 |
Cost of Revenue | 9,324 | 639 | ||
Free Cash Flow | -39,430 | -55,567 | -34,692 | -24,879 |
Cash | 9,291 | 13,523 | 14,852 | 10,288 |
Basic Shares | 36,160 | 36,075 | 34,294 | 24,104 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.23 |
2024-09-30 | -$0.15 |
2024-06-30 | $0.25 |
2024-03-31 | -$0.69 |
